Anti-cyclic citrullinated peptide antibody in bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis
The corrected BALF ACPA level might be an important biomarker for identifying IPF phenotypes with favourable outcomes.
Authors
- Kazuko Uno
- Toyohiro Hirai (ORCID: https://orcid.org/0000-0002-7431-9044)
- Tomohiro Handa (ORCID: https://orcid.org/0000-0002-3378-6412)
- Kohei Ikezoe (ORCID: https://orcid.org/0000-0003-1097-2084)
- Ryobu Mori
- Kiminobu Tanizawa
Institutions
- Kyoto University (JP)
- Kyoto Medical Center (JP)
- Louis Pasteur Center for Medical Research (JP)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1186/s12890-025-04088-9
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00